Merck Global Health Innovation Fund is the strategic corporate venture capital arm of Merck & Co., Inc. The fund focuses on investments in digital health technologies that can lead to improved patient outcomes, enhance healthcare efficiency, and support Merck's strategic interests. It partners with innovative companies to accelerate the development and commercialization of health solutions.

Merck Global Health Innovation Fund

Intelligent Health organizes a healthtech summit that connects clinicians, technologists, and executives to discuss the use of AI in medicine. The summit aims to advance conversations and collaboration in the healthcare sector, focusing on innovations and solutions in health technology.

Intelligent Health

Nobias Therapeutics is a clinical-stage company developing novel small-molecule therapeutics for rare diseases, focusing initially on pediatric indications and expanding to adults and non-rare indications. This description is self-described.

Nobias Therapeutics

SC Master Fund supports local innovation, entrepreneurs, and venture funds in Southern California by realigning capital and expertise towards promising technology startups.

Metric
Company Name	Merck Global Health Innovation Fund	Intelligent Health	Nobias Therapeutics	SC Master Fund
Symbol
MSH ID	COM:MERCKGHIFUND	AI:INTELLIGENTHEALTH	COM:NOBIASTX	COM:SCMASTERFUND
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Financial Services & Finance
Industry	Healthcare & Health Services	Health Technology	Biotechnology	Investment Management
Country		CH	US	US
Stage
Employee Count	11
Website	merckghifund.com	intelligenthealth.ai	nobiastx.com	scmasterfund.com
LinkedIn		intelligent-health-ai-ltd	nobias-therapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MERC

COM:MERCKGHIFUND

Merck Global Health Innovation Fund

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue